regulatory
confidence high
sentiment negative
materiality 0.60
Avalon GloboCare Corp. (ALBT): Nasdaq/NYSE listing notice — Avalon GloboCare receives Nasdaq bid price deficiency notice; 180-day cure period to May 1, 2024
Avalon GloboCare Corp.
- Nasdaq notified ALBT on Nov 3, 2023 that bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until May 1, 2024, to regain compliance by closing at $1.00+ for 10 straight days.
- If not compliant by May 1, 2024, Avalon may qualify for a second 180-day compliance period.
- Failure to regain compliance could lead to delisting; company may appeal to a Nasdaq hearings panel.
- No immediate impact on trading; management evaluating strategies to address the deficiency.